These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


162 related items for PubMed ID: 15156428

  • 1. Modified directly observed therapy for the treatment of HIV-seropositive substance users: lessons learned from a pilot study.
    Macalino GE, Mitty JA, Bazerman LB, Singh K, McKenzie M, Flanigan T.
    Clin Infect Dis; 2004 Jun 01; 38 Suppl 5():S393-7. PubMed ID: 15156428
    [Abstract] [Full Text] [Related]

  • 2. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users.
    Macalino GE, Hogan JW, Mitty JA, Bazerman LB, Delong AK, Loewenthal H, Caliendo AM, Flanigan TP.
    AIDS; 2007 Jul 11; 21(11):1473-7. PubMed ID: 17589194
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effectiveness and tolerability of a once-daily amprenavir/ritonavir-containing highly active antiretroviral therapy regimen in antiretroviral-naïve patients at risk for nonadherence: 48-week results after 24 weeks of directly observed therapy.
    Jayaweera DT, Kolber MA, Brill M, Tanner T, Campo R, Rodriguez A, Chu HM, Garg V.
    HIV Med; 2004 Sep 11; 5(5):364-70. PubMed ID: 15369512
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Use of community-based, directly observed therapy for HIV infection: lessons learned for treatment of hepatitis C virus infection.
    Flanigan TP, Taylor LE, Mitty JA.
    Clin Infect Dis; 2005 Apr 15; 40 Suppl 5():S346-8. PubMed ID: 15768346
    [Abstract] [Full Text] [Related]

  • 8. The feasibility of a community-based directly administered antiretroviral therapy program.
    Wohl AR, Garland WH, Squires K, Witt M, Larsen R, Kovacs A, Hader S, Weidle PJ.
    Clin Infect Dis; 2004 Jun 01; 38 Suppl 5():S388-92. PubMed ID: 15156427
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD, Keruly JC.
    Clin Infect Dis; 2007 Feb 01; 44(3):441-6. PubMed ID: 17205456
    [Abstract] [Full Text] [Related]

  • 16. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD, Préau M, Vincent E, Carrieri MP, Gallais H, Lepeu G, Gastaut JA, Moatti JP, Spire B, MANIF 2000 Study Group.
    Antivir Ther; 2005 Feb 01; 10(1):53-61. PubMed ID: 15751763
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Direct observation therapy-highly active antiretroviral therapy in a resource-limited setting: the use of community treatment support can be effective.
    Idoko JA, Agbaji O, Agaba P, Akolo C, Inuwa B, Hassan Z, Akintunde L, Badung B, Muazu M, Danang M, Imade G, Sankale JL, Kanki P.
    Int J STD AIDS; 2007 Nov 01; 18(11):760-3. PubMed ID: 18005510
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.